Sinopharm Group Co. Ltd. (FRA:X2S)

Germany flag Germany · Delayed Price · Currency is EUR
1.991
-0.010 (-0.50%)
At close: Sep 26, 2025
-0.50%
Market Cap6.24B
Revenue (ttm)68.44B
Net Income (ttm)809.54M
Shares Outn/a
EPS (ttm)0.26
PE Ratio7.70
Forward PE6.71
Dividend0.08 (4.09%)
Ex-Dividend DateJun 16, 2025
Volume17,921
Average Volume7,634
Open1.991
Previous Close2.001
Day's Range1.991 - 1.991
52-Week Range1.934 - 2.717
Betan/a
RSI41.63
Earnings DateOct 31, 2025

About Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 2003
Employees 108,217
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol X2S
Full Company Profile

Financial Performance

In 2024, Sinopharm Group's revenue was 584.51 billion, a decrease of -2.02% compared to the previous year's 596.57 billion. Earnings were 7.05 billion, a decrease of -22.14%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.